Mustang Bio

Mustang Bio Financial Leverage

The Financial Leverage (Equity Multiplier) of Mustang Bio (MBIO) as of Nov 19, 2026 is 1.85. In the previous year, Financial Leverage (Equity Multiplier) was -2.40 — a change of -176.82% (higher).

Financial Leverage

1.85

YoY

-176.82%

Last updated:

Financial Leverage (Equity Multiplier) of Mustang Bio is 2025 1.85 . Financial Leverage (Equity Multiplier) of Mustang Bio was 2024 -2.40 . It decreases by -176.82% higher compared to the previous year.

The Mustang Bio Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.17 USD
Jan 1, 2019
1.42 USD
Jan 1, 2020
1.12 USD
Jan 1, 2021
1.11 USD
Jan 1, 2022
2.00 USD
Jan 1, 2023
144.24 USD
Jan 1, 2024
-2.40 USD
Jan 1, 2025
1.85 USD
The Mustang Bio Financial Leverage history
YEARFinancial LeverageYoY
1.85-176.82%
-2.40-101.67%
144.24+7,121.87%
2.00+79.36%
1.11-0.26%
1.12-21.48%
1.42+21.05%
1.17+10.70%
1.06-6.32%
1.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mustang Bio Stock analysis

What does Mustang Bio do? Mustang Bio Inc., based in New York City, is a clinical-stage biopharmaceutical company operating in the Health Care sector. It specializes in developing proprietary CAR T immunotherapies and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. The company, listed on 22 August 2017, focuses on translating cell and gene therapy breakthroughs into potential cures, with pipeline programs including MB-107 for X-linked severe combined immunodeficiency and MB-102 for acute myeloid leukemia. Mustang Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mustang Bio stock

Financial Leverage (Equity Multiplier) of Mustang Bio is 1.85 in 2025.

Financial Leverage (Equity Multiplier) of Mustang Bio changed from -2.40 to 1.85, representing a -176.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Mustang Bio since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Mustang Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Mustang Bio

All Key Metrics — Mustang Bio